---
title: "Laromestrocel (Lomecel‑B) reduces neuroinflammation and preserves brain volume and cognition in mi"
id: "medrxiv-1-laromestrocel-preserves-brain-volume-and-cognitive-function-in-alzheimers"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-laromestrocel-preserves-brain-volume-and-cognitive-function-in-alzheimers"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1?rss=1"
published_at: "2026-09-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Laromestrocel (Lomecel‑B) reduces neuroinflammation and preserves brain volume and cognition in mi
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-laromestrocel-preserves-brain-volume-and-cognitive-function-in-alzheimers
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1?rss=1)
- **Published At:** 2026-09-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Neuroinflammation drives brain atrophy and cognitive decline in Alzheimer’s disease; this study evaluated the effects of the mesenchymal stem cell therapy **laromestrocel** (Lomecel‑B) in subjects with mild AD. - Randomized data come from 49 subjects (treated groups and placebo, placebo N=9) followed to 39 weeks; two active dose regimens reported: **25 million cells × 4 monthly** doses (25Mx4; N≈11) and **100 million cells × 4 monthly** doses (100Mx4; N≈10). - Significant reductions in neuroinflammation vs placebo were detected in key AD regions at week 39: left hippocampus (25Mx4 and 100Mx4; p<0.001), left temporal cortex (25Mx4; p=0.007), left parietal cortex (25Mx4 at week 26; p=0.042), and the medulla (25Mx4 and 100Mx4; p=0.007). - Decreased neuroinflammation correlated with reduced hippocampal atrophy (R = -0.326; p=0.040; N=40) and with improved cognitive scores, notably MoCA (hippocampus × MoCA: R = -0.401; p=0.011; N=40). - Plasma neurogranin, a marker consistent with synaptic loss, was reduced in the 25Mx4 group (p=0.023; N=11), supporting preservation of synaptic integrity. - Blood biomarker analysis suggested peripheral immune engagement consistent with a multimodal mechanism of action that converges on anti‑neuroinflammatory effects. - Overall, the authors report sustained anti‑neuroinflammatory effects of **laromestrocel** associated with less brain tissue destruction and improved clinical function over the study period. - Trial registration: Clinical Trial NCT05233774. Ethical approval obtained from Western‑Copernicus Group IRB on 24 November 2021. Conflicts of interest disclosed for authors with ties to Longeveron and related entities. - Data access: minimum dataset and protocol/statistical analysis plan available on request under data use agreement; IND #16524 referenced for the trial protocol.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=Gqq5PHWO0ds1AjTCCYluC.lQ5xS.MOZYc1ps3WoXCHg-1789706347.6242678-1.2.1.1-GFWLG8yrDc6W.v3yMNLnfix2q09m_0T5We8P1gj54Qtq35v9vvLB7mxxsewEurW5) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Laromestrocel preserves brain volume and cognitive function in Alzheimers disease by inhibiting neuroinflammation [ View ORCID Profile](http://orcid.org/0000-0003-4555-4093)Brian G Rash, Sofya Levitina, Jeffrey Botbyl, Chris Conklin, Madhura Ingalhalikar, [ View ORCID Profile](http://orcid.org/0000-0002-7751-5032)Joshua M Hare doi: https://doi.org/10.64898/2026.09.16.26363132 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Brian G Rash 1 Longeveron, INC; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Brian%2BG%2BRash%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rash%20BG&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABrian%2BG%2BRash%2B) * [ORCID record for Brian G Rash](http://orcid.org/0000-0003-4555-4093 "Open in new tab") * For correspondence: brash@longeveron.com Sofya Levitina 2 Longeveron Inc; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sofya%2BLevitina%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Levitina%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASofya%2BLevitina%2B) Jeffrey Botbyl 3 Provonix, Inc; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jeffrey%2BBotbyl%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Botbyl%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJeffrey%2BBotbyl%2B) Chris Conklin 4 Clario, Inc * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chris%2BConklin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Conklin%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChris%2BConklin%2B) Madhura Ingalhalikar 4 Clario, Inc * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Madhura%2BIngalhalikar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ingalhalikar%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMadhura%2BIngalhalikar%2B) Joshua M Hare 2 Longeveron Inc; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joshua%2BM%2BHare%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hare%20JM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJoshua%2BM%2BHare%2B) * [ORCID record for Joshua M Hare](http://orcid.org/0000-0002-7751-5032 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1302579/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1302579/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1302579/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1302579/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1302579/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Neuroinflammation is a principal driver of brain atrophy and cognitive decline in Alzheimers disease (AD). Here we show that laromestrocel, a mesenchymal stem cell therapy, inhibits progressive brain inflammation in subjects (n=49) with mild AD, with the strongest effect seen in core AD brain regions: the left hippocampus (25 million cells (M)x4 monthly dose group; p The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.14.26360893v1 "One night of closed-loop auditory stimulation during sleep enhances memory consolidation in patients with Alzheimer's Disease")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.16.26363229v1 "Global immuno-epidemiology and the persistence of mpox clade IIb in MSM") Posted September 17, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/17/2026.09.16.26363132.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.16.26363132v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/17/2026.09.16.26363132.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Laromestrocel preserves brain volume and cognitive function in Alzheimers disease by inhibiting neuroinflammation Brian G Rash, Sofya Levitina, Jeffrey Botbyl, Chris Conklin, Madhura Ingalhalikar, Joshua M Hare medRxiv 2026.09.16.26363132; doi: https://doi.org/10.64898/2026.09.16.26363132 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.16.26363132v1%26text%3DLaromestrocel%2520preserves%2520brain%2520volume%2520and%2520cognitive%2520function%2520in%2520Alzheimers%2520disease%2520by%2520inhibiting%2520neuroinflammation "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.16.26363132v1%26t%3DLaromestrocel%2520preserves%2520brain%2520volume%2520and%2520cognitive%2520function%2520in%2520Alzheimers%2520disease%2520by%2520inhibiting%2520neuroinflammation "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.16.26363132v1%26title%3DLaromestrocel%2520preserves%2520brain%2520volume%2520and%2520cognitive%2520function%2520in%2520Alzheimers%2520disease%2520by%2520inhibiting%2520neuroinflammation%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.16.26363132v1%26title%3DLaromestrocel%2520preserves%2520brain%2520volume%2520and%2520cognitive%2520function%2520in%2520Alzheimers%2520disease%2520by%2520inhibiting%2520neuroinflammation "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.16.26363132) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.16.26363132v1&count=horizontal&via=&text=Laromestrocel%20preserves%20brain%20volume%20and%20cognitive%20function%20in%20Alzheimers%20disease%20by%20inhibiting%20neuroinflammation&counturl=www.medrxiv.org/content/10.64898/2026.09.16.26363132v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (617) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (903) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (334) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4821) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (479) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (416) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (650) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1631) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15959) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (33) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1203) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7055) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (733) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1066) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5053) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1435) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1771) * [Hematology](https://www.medrxiv.org/collection/hematology) (586) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1346) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16298) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1174) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (670) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (155) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (725) * [Neurology](https://www.medrxiv.org/collection/neurology) (7284) * [Nursing](https://www.medrxiv.org/collection/nursing) (368) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1082) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1243) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1005) * [Oncology](https://www.medrxiv.org/collection/oncology) (3611) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1054) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (398) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (457) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (472) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (709) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1802) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (737) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (768) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5908) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9765) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2429) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1454) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1249) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (642) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (772) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (578) * [Surgery](https://www.medrxiv.org/collection/surgery) (780) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (305) * [Urology](https://www.medrxiv.org/collection/urology) (291) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferr
## Related Clinical Research

- [Kennedy launches ARPA-H initiative to accelerate autism diagnoses and research](https://medichelpline.com/clinical-feed/stat-news-0-kennedy-announces-new-effort-to-speed-up-autism-diagnoses.md)
- [Startup to test psychedelic-like drug for Parkinson’s apathy — STAT+ report](https://medichelpline.com/clinical-feed/stat-news-0-stat-new-startup-to-test-psychedelic-like-drug-against-parkinson-s-symptom.md)
- [Antihypertensive Drug Class and Risk of Incident Alzheimer’s Disease and Related Dementias: Replic](https://medichelpline.com/clinical-feed/medrxiv-17-antihypertensive-medication-class-and-incident-alzheimers-disease-and-related.md)
- [Plasma biomarkers linked to longitudinal Alzheimer’s-related brain atrophy patterns](https://medichelpline.com/clinical-feed/medrxiv-19-association-of-plasma-biomarkers-with-longitudinal-change-in-age-and-alzheimer.md)
- [Choroid Plexus Calcification in Lateral, Third, and Fourth Ventricles: Links to Aging, Brain Struc](https://medichelpline.com/clinical-feed/biorxiv-21-regional-choroid-plexus-calcifications-and-their-associations-with-aging-brain.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.